NetJets To Buy Up To 1,500 Citations

Gemini Sparkle

Key Takeaways:

  • Textron Aviation and NetJets announced a record-breaking 15-year deal for the purchase of up to 1,500 Citation jets.
  • NetJets will serve as the launch partner for Textron's new Citation Ascend, with deliveries projected to begin in 2025 after type certification.
  • The extensive fleet agreement also includes the popular Citation Latitude and Longitude models.
  • The deal reinforces NetJets customers' preference for Citation aircraft and aims to provide enhanced versatility and flexibility for their global missions.
See a mistake? Contact us.

On Wednesday, Textron Aviation and NetJets announced the terms of a record-breaking deal between the long-standing partner companies for the purchase of up to 1,500 Citation jets. NetJets will also serve as the launch partner for the Citation Ascend, which was announced at the National Business Aviation Association’s European Business Aviation Convention and Expo in May. The fleet agreement extends over the next 15 years, with deliveries of the Ascend to begin after type certification is achieved and entry into service projected for 2025. The deal also includes the Citation Latitude and Longitude.

“NetJets customers around the world continually select Citations as their aircraft of choice,” said Ron Draper, president and CEO, Textron Aviation. “We’re honored to be the largest provider of industry-leading aircraft to NetJets and look forward to continuing to work together to design and deliver the best aviation experience based on customer feedback. Expanding and adding the Citation Ascend to the NetJets fleet will provide its global customers with even more versatility and flexibility to accomplish their missions, building upon the exceptional performance and popularity of the Latitude and Longitude.”

Sign-up for newsletters & special offers!

Get the latest stories & special offers delivered directly to your inbox

SUBSCRIBE

Please support AVweb.

It looks like you’re using an ad blocker. Ads keep AVweb free and fund our reporting.
Please whitelist AVweb or continue with ads enabled.